Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+

  Malignant Lymphoma

  Free Subscription


2 AJR Am J Roentgenol
1 Am J Hematol
3 Blood
1 Bone Marrow Transplant
1 Br J Dermatol
1 Br J Haematol
5 Haematologica
1 J Clin Oncol
2 Leukemia
1 Oncology

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    AJR Am J Roentgenol

  1. KIM TH, Woo S, Yoon SH, Halpenny DF, et al
    CT Characteristics of Non-Small Cell Lung Cancer With Anaplastic Lymphoma Kinase Rearrangement: A Systematic Review and Meta-Analysis.
    AJR Am J Roentgenol. 2019 Aug 15:1-14. doi: 10.2214/AJR.19.21485.
    PubMed     Text format     Abstract available

  2. PFAU D, Smith DA, Beck R, Gilani KA, et al
    Primary Mediastinal Large B-Cell Lymphoma: A Review for Radiologists.
    AJR Am J Roentgenol. 2019 Aug 15:1-17. doi: 10.2214/AJR.19.21225.
    PubMed     Text format     Abstract available

    Am J Hematol

  3. HARTMANN S, Plutschow A, Mottok A, Bernd HW, et al
    The time to relapse correlates with the histopathological growth pattern in nodular lymphocyte predominant Hodgkin lymphoma.
    Am J Hematol. 2019 Aug 8. doi: 10.1002/ajh.25607.
    PubMed     Text format     Abstract available


  4. HICKS LK, Feld JJ
    Resolved HBV and anti-CD20 therapy.
    Blood. 2019;133:104-106.
    PubMed     Text format    

    Localized FL: how long in response to be cured?
    Blood. 2019;133:187-188.
    PubMed     Text format    

  6. CHEN R, Zinzani PL, Lee HJ, Armand P, et al
    Pembrolizumab in relapsed or refractory Hodgkin lymphoma: Two-year follow-up of KEYNOTE-087.
    Blood. 2019 Aug 13. pii: blood.2019000324. doi: 10.1182/blood.2019000324.
    PubMed     Text format     Abstract available

    Bone Marrow Transplant

  7. ATOUI A, El Labban M, Ghaoui N, El Darsa H, et al
    Complete remission of seronegative rheumatoid arthritis following haplo-identical stem cell transplantation for peripheral T-cell lymphoma.
    Bone Marrow Transplant. 2019 Aug 12. pii: 10.1038/s41409-019-0635.
    PubMed     Text format    

    Br J Dermatol

  8. BYRNE N, Hughes R, Murphy LA, Kirby B, et al
    Remission of severe hidradenitis suppurativa following chemotherapy for Hodgkin's lymphoma.
    Br J Dermatol. 2019 Aug 9. doi: 10.1111/bjd.18423.
    PubMed     Text format     Abstract available

    Br J Haematol

  9. MELLERT K, Martin M, Lennerz JK, Ludeke M, et al
    The impact of SOCS1 mutations in diffuse large B-cell lymphoma.
    Br J Haematol. 2019 Aug 12. doi: 10.1111/bjh.16147.
    PubMed     Text format     Abstract available


  10. SCHIEPPATI F, Balzarini P, Fisogni S, Re A, et al
    An increase in MYC copy number has a progressive negative prognostic impact in patients with diffuse large B-cell and high-grade lymphoma, who may benefit of intensified treatment regimens.
    Haematologica. 2019 Aug 8. pii: haematol.2019.223891.
    PubMed     Text format     Abstract available

  11. TANAKA J, Tanaka N, Wang YH, Mistuhashi K, et al
    Phase I study of cellular therapy using ex vivo expanded NK cell from autologous peripheral blood mononuclear cells combined with rituximab-containing chemotherapy for relapsed CD20-positive malignant lymphoma patients.
    Haematologica. 2019 Aug 8. pii: haematol.2019.226696.
    PubMed     Text format    

  12. MIKA T, Ladigan S, Baraniskin A, Vangala D, et al
    Allogeneic hematopoietic stem cell transplantation for primary central nervous system lymphoma.
    Haematologica. 2019 Aug 8. pii: haematol.2019.227199.
    PubMed     Text format    

  13. LI Z, Song Y, Zhang Y, Li C, et al
    Genomic and outcome analysis of adult T-cell lymphoblastic lymphoma.
    Haematologica. 2019 Aug 14. pii: haematol.2019.220863.
    PubMed     Text format    

  14. TEDESCHI A, Greil R, Demirkan F, Robak T, et al
    A cross-trial comparison of single-agent ibrutinib versus chlorambucil-obinutuzumab in previously untreated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.
    Haematologica. 2019 Aug 14. pii: haematol.2019.223743.
    PubMed     Text format    

    J Clin Oncol

  15. ZINZANI PL, Santoro A, Gritti G, Brice P, et al
    Nivolumab Combined With Brentuximab Vedotin for Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma: Efficacy and Safety From the Phase II CheckMate 436 Study.
    J Clin Oncol. 2019 Aug 9:JCO1901492. doi: 10.1200/JCO.19.01492.
    PubMed     Text format     Abstract available


  16. CRISTOFOLETTI C, Bresin A, Picozza M, Picchio MC, et al
    Blood and skin-derived Sezary cells: differences in proliferation-index, activation of PI3K/AKT/mTORC1 pathway and its prognostic relevance.
    Leukemia. 2019;33:1231-1242.
    PubMed     Text format     Abstract available

  17. TORREY H, Khodadoust M, Tran L, Baum D, et al
    Targeted killing of TNFR2-expressing tumor cells and Tregs by TNFR2 antagonistic antibodies in advanced Sezary syndrome.
    Leukemia. 2019;33:1206-1218.
    PubMed     Text format     Abstract available


  18. METZINGER MN, Verghese C, Hamouda DM, Lenhard A, et al
    Chimeric Antigen Receptor T-Cell Therapy: Reach to Solid Tumor Experience.
    Oncology. 2019;97:59-74.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.